CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Contribution of Cardiac Sodium Channel β-Subunit Variants to Brugada Syndrome.
|
26179811 |
2015 |
Brugada Syndrome 1
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Contribution of Cardiac Sodium Channel β-Subunit Variants to Brugada Syndrome.
|
26179811 |
2015 |
Brugada Syndrome 1
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort.
|
26173111 |
2015 |
Nodal rhythm disorder
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.
|
23559163 |
2013 |
Other specified cardiac arrhythmias
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.
|
23559163 |
2013 |
Sinus Node Dysfunction (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.
|
23559163 |
2013 |
Ectopic rhythm
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.
|
23559163 |
2013 |
CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.
|
23559163 |
2013 |
Brugada Syndrome 1
|
0.300 |
Biomarker
|
disease |
CLINGEN |
A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.
|
23559163 |
2013 |
Nodal rhythm disorder
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Other specified cardiac arrhythmias
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Sinus Node Dysfunction (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Ectopic rhythm
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Brugada Syndrome 1
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Otitis Media
|
0.200 |
Biomarker
|
disease |
RGD |
Suppression of epithelial ion transport transcripts during pneumococcal acute otitis media in the rat.
|
12206256 |
2002 |
Visual seizure
|
0.200 |
Biomarker
|
disease |
RGD |
mRNA coding for voltage-gated sodium channel beta2 subunit in rat central nervous system: cellular distribution and changes following kainate-induced seizures.
|
9672387 |
1998 |
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
|
19074352 |
2008 |
Cardiac Arrest
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Paroxysmal ventricular tachycardia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sick Sinus Syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Syncope
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Supraventricular tachycardia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ventricular Fibrillation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|